Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal studyIlaria Cetta, Massimo Filippi, Roberta Messina et al.|Neurological Sciences|2022Cited by 27
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life studyLaura Zanandrea, Massimo Filippi, Bruno Colombo et al.|European Journal of Neurology|2024Cited by 5
Anti-cgrp Monoclonal Antibodies in Chronic Migraine Prophilaxys: Efficacy and Safety in Patients Treated With Botulinum Toxin aCalogera Butera, Ubaldo Del Carro, Ilaria Cetta et al.|Research Square|2023Cited by 1
Investigating Glymphatic Dysfunction in Migraine: A Role in Headache Pain and Migraine Chronification? (P4-12.002)Roberta Messina, Massimo Filippi, Elisabetta Pagani et al.|Neurology|2025Cited by 1
Clinical Correlates of Longitudinal Hypothalamic-Pontine Functional Changes in Migraine Patients (S41.008)Roberta Messina, Massimo Filippi, Paola Valsasina et al.|Neurology|2023Cited by 0